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Summary
Simkania negevensis is an obligate intracellular bac-
terial pathogen that grows in amoeba or human cells
within a membrane-bound vacuole forming endoplas-
mic reticulum (ER) contact sites. The membrane of
this Simkania-containing vacuole (SnCV) is a critical
host–pathogen interface whose origin and molecular
interactions with cellular organelles remain poorly
defined. We performed proteomic analysis of purified
ER-SnCV-membranes using label free LC-MS2 to
define the pathogen-containing organelle composi-
tion. Of the 1,178 proteins of human and 302 proteins
of Simkania origin identified by this strategy, 51 host
cell proteins were enriched or depleted by infection
and 57 proteins were associated with host endosomal
transport pathways. Chemical inhibitors that selec-
tively interfere with trafficking at the early endosome-
to-trans-Golgi network (TGN) interface (retrograde
transport) affected SnCV formation, morphology and
lipid transport. Our data demonstrate that Simkania
exploits early endosome-to-TGN transport for nutri-
ent acquisition and growth.
Introduction
The obligate intracellular, Gram-negative bacterium Sim-
kania negevensis (Sn) belongs to the family Simkaniaceae
in the order Chlamydiales (Everett et al., 1999; Kahane
et al., 2007). The genome of Sn is approximately 2.5 Mbp
in size and thus two to three times larger than the genome
of Chlamydia (Collingro et al., 2011). Chlamydiae are
found as symbionts and pathogens in a wide range of
eukaryotes, including protists, invertebrates and verte-
brates (Subtil et al., 2014). Sn is able to replicate in
amoebae, human and simian epithelial cells and mac-
rophages (Kahane et al., 1993; 2007) and has been asso-
ciated with infections of the upper respiratory tract in
infants and adults (Lieberman et al., 1997; Kahane et al.,
1998; Horn, 2008; Lamoth and Greub, 2010). Infections
with the two closely related human pathogenic bacteria
Chlamydia pneumoniae and Chlamydia psittaci can cause
community acquired or animal transmitted pneumonia,
chronic bronchitis and chronic asthma (Hughes et al.,
1997; Hahn and McDonald, 1998; Harkinezhad et al.,
2009).
Similar to Chlamydia, Sn undergoes a unique develop-
mental cycle during intracellular replication. Infection is
initiated by entry of an electron dense elementary body
(EB) into the host cell. Inside of a membrane-bound com-
partment, termed inclusion, EBs differentiate into reticulate
bodies (RBs) within a short period of time. RBs are the
metabolically active and replicative form of Chlamydia and
divide by binary fission. At the end of every multiplication
phase, RBs re-differentiate into EBs to start a new infection
cycle (Dautry-Varsat et al., 2005; Hybiske and Stephens,
2007). Sn has a longer life cycle than other chlamydial spe-
cies with a replication plateau at day 3 post infection and
the release of EBs by host cell-lysis after 5–12 days post
infection (Kahane et al., 1993; 1999; 2002). Long-term
growth is likely connected to inhibition of host cell death
induced by Simkania infection (Karunakaran et al., 2011).
The biogenesis of the chlamydial inclusion and interac-
tion with the host cell have been intensively investigated
(for a review, see Fields and Hackstadt, 2002). Once
inside the cell, Chlamydia resides within a membrane-
surrounded host-derived vacuole within the cytoplasm
(Hackstadt et al., 1997). Shortly after, the vacuole is trans-
ported to the microtubule organising centre in a dynein
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dependent manner likely through interaction with the dyn-
actin subunit p150(Glued) (Clausen et al., 1997;
Hackstadt, 2000; Grieshaber et al., 2003). Individual
inclusions from C. trachomatis fuse to form a single large
vacuole, whereas many other Chlamydiales develop mul-
tiple small inclusions (Clausen et al., 1997). Chlamydia
directly modifies the inclusion by secretion of inclusion
membrane proteins (Incs) that also extend to the cytosolic
face of the inclusion membrane (Rockey et al., 1997;
Hackstadt et al., 1999; Scidmore and Hackstadt, 2001).
The action of bacterial proteins in the chlamydial inclusion
membrane is assumed to, e.g. prevent endolysosomal
fusion, avoid host immune responses and support fusion
with sphingomyelin and cholesterol-containing exocytic
vesicles from the Golgi apparatus (Scidmore et al.,
1996b; Ojcius et al., 1997; Hackstadt et al., 1999;
Carabeo et al., 2003). It is currently unknown how well
conserved basic molecular mechanisms behind these
processes are within the order Chlamydiales.
Sn forms a continuous membrane system spanning the
host cell, and this is clearly distinct from the single vacu-
olar structure of Chlamydia (Mehlitz et al., 2014). Interest-
ingly, Sn shapes extensive endoplasmic reticulum (ER)
contact sites, which are reminiscent of inclusion-ER
contact sites also termed pathogen synapses (Derre
et al., 2011; Dumoux et al., 2012; Mehlitz et al., 2014).
The recent discovery of Inc proteins within other members
of the Chlamydiales, like Parachlamydia, Waddlia and
Simkania, and their low degree of conservation makes it
highly likely that the interaction with the host is much more
diverse than previously anticipated (Fields and Hackstadt,
2002; Heinz et al., 2010; Collingro et al., 2011). Only three
putative Inc proteins are conserved among Chlamydiae,
and just a few members can enter and multiply in mam-
malian cells, indicating a dependency on the host cell type
or different molecular mechanisms. The identification and
characterisation of Inc or Inc-like proteins in the Sn
vacuole could reveal the unique molecular interaction with
the host ER.
The ER forms a highly branched membrane network
arranged in tubes, sheets and cisternae enclosing a
fluid-filled interior. Parts of the ER membrane directly
associate with the nuclear envelope and extend into the
cytosol spanning to the plasma membrane (PM) (English
et al., 2009). The ER can be divided into smooth and
rough ER (SER and RER). RER can easily be identified
through lining ribosomes and is associated with multiple
cellular functions including protein synthesis, folding or
quality control as well as Ca2+ homeostasis and regula-
tion of apoptosis (Breckenridge et al., 2003; Rizzuto
et al., 2009; Braakman and Bulleid, 2011). The SER is
responsible for vesicle formation, budding and fusion
processes, is free of ribosomes and forms a highly
complex tubular structure (Shibata et al., 2006; Bravo
et al., 2013). In eukaryotic cells, the ER interacts with
the Golgi apparatus through bidirectional vesicle traffick-
ing, co-ordinating cellular protein and lipid transport
(Ghaemmaghami et al., 2003).
Proteins on donor organelles, e.g. vSNAREs (vesicle
soluble N-ethylmaleimide sensitive factor attachment
receptor) guide the fusion with the target organelle via
interaction with tSNAREs (target SNAREs) (Bonifacino
and Glick, 2004). An example of this mechanism is pro-
vided by COPI and II vesicles, where COPII vesicles are
transported from the ER to the Golgi (anterograde trans-
port) and COPI vesicles are involved in the retrograde
backhaul (Brandizzi and Barlowe, 2013). Also non-
vesicular mechanisms have been reported for the transfer
of proteins and lipids between organelles. Arf1/COPI com-
plexes and the ER to Golgi ceramide transfer protein
CERT mediate such non-vesicular transport (Hanada
et al., 2003; Hanada, 2010; Wilfling et al., 2014). This type
of transport bridges short distances, e.g. between ER and
Golgi membranes, and is required for chlamydial inclusion
development (Derre et al., 2011; Elwell et al., 2011;
Dumoux et al., 2012). In contrast, data for evolutionary
related organisms like Simkania are missing. Simkania
forms numerous ER-vacuole contact sites (Mehlitz et al.,
2014) and might thereby facilitate uptake of metabolites or
lipids required for growth.
Chlamydia requires host-derived lipids like sphingomy-
elin (SM) and cholesterol for development (Hackstadt
et al., 1995; Scidmore et al., 1996a,b; Carabeo et al.,
2003). The inclusion membrane thereby constitutes a
critical intracellular barrier as these lipids have to be
transported into the inclusion to be accessible for the
bacteria. As the inclusion membrane is impermeable to
small molecules (Heinzen and Hackstadt, 1997), it is
thought that Chlamydia acquires lipids from vesicles
from the secretory pathway that fuse with the inclusion
membrane (Carabeo et al., 2003; Heuer et al., 2009;
Derre et al., 2011; Elwell et al., 2011). This includes the
interception of SM-containing Golgi-derived exocytic
vesicles destined for the PM or fusion with multi-
vesicular body-derived vesicles (MBV) (Hackstadt et al.,
1995; Scidmore et al., 1996b; Beatty, 2006; 2008;
Robertson et al., 2009). The latter could also play a role
in delivering nutrient into the inclusion that are then
taken up by Chlamydia via bacterial transporters, per-
meases and translocases based on active transport pro-
cesses (Saka et al., 2011). Golgi fragmentation induced
by C. trachomatis has been shown to be important for
SM acquisition during the later stages of infection and
may be required for subsequent fusion with exocytic
vesicles by a mechanism involving Rab6 and Rab11
(Heuer et al., 2009; Rejman Lipinski et al., 2009).
Here, we established an ER-Simkania negevensis con-
taining vacuole (SnCV) isolation protocol to define the
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composition of the organelle by label free LC-MS2. Our
data suggest the depletion of components of endosomal
trafficking, ER to Golgi as well as exocytic transport in the
SnCV. Interestingly, proteins associated with recycling
endosomal as well as Golgi to ER transport were enriched
in the SnCV, suggesting a role of these pathways in nutri-
ent uptake by Simkania. In line with this, interfering with
retrograde transport affected Simkania replication and
SnCV formation. SnCV formation and ceramide acquisi-
tion were severely affected by blocking retrograde traffick-
ing underlining the importance of this route for intracellular
adaptation of Simkania.
Results
Purification of ER-SnCV membranes
Simkania negevensis containing vacuoles are intimately
associated with the ER of their host cell (Mehlitz et al.,
2014). It is unknown how the ER-SnCV interaction is
established and whether it affects the composition of the
ER. To investigate the effect of infection on the proteome
of the ER membranes, the organelle had to be isolated
from control and infected cells (Huber et al., 2003). We
therefore established the isolation of crude ER- and
ER-SnCV-membranes from control and S. negevensis
infected cells (see Fig. 1A and Experimental procedures
for more details). Individual isolation steps were analysed
by light-microscopy to confirm cell swelling and mechani-
cal rupture (Fig. 1B). Sequential centrifugation steps led
to the fractionation into pre-nuclear (PNF), pre-
mitochondrial (PMF) and crude microsomal ER-fraction
(CMF) (Fig. 1A). The quality of the ER-SnCV membrane
purification was controlled by immunoblotting by detecting
marker proteins for cytoskeleton (ß-Actin), mitochondria
(Sam50) and nuclei (Lamin B1) (Fig. 1C). Calnexin an ER
membrane protein was detected within PMF and CMF
fractions indicating the strong association of the ER with
organelles like mitochondria (Fig. 1C). A subset of soluble
ER proteins like PDI and ERp72 were found in the PMF
and only to a low extend in the CMF, which could be due
to association with other organelles (Fig. 1C). KDEL (Lys-
Asp-Glu-Leu) ER retention signal containing proteins
were selectively enriched in the CMF (Fig. 1C). Bacteria
were strongly depleted from the CMF as was monitored
by detecting the bacterial heat shock protein GroEL
(Fig. 1C). Residual GroEL was most likely derived from
broken bacteria, as intact bacteria were hardly detectable
in the CMF by transmission electron microscopy (TEM)
(Fig. 1D). Interestingly, we observed only a fraction of total
bacterial proteins within the CMF fraction likely represent-
ing bacterial proteins localised to the SnCV membrane
(Fig. 1C). These results show the isolation of crude
ER-SnCV membranes from Simkania infected cells as
well as the modulation of the ER composition through
Simkania infection.
Proteome analysis of crude ER-SnCV
membranes (CMF)
We then analysed the crude ER-SnCV membrane fraction
(CMF) of three biological replicates by LC-MS2 to identify
Simkania infection-mediated changes of ER composition
and identified 1178 human and 302 Simkania proteins in
the infected samples (Fig. 2A and Supplementary Tables
S1 and S3). One hundred twenty-three out of 302 (41%)
identified bacterial proteins were hypothetical proteins
with no known function or homology upon database
searches respectively (Supplementary Table S3). Inc pro-
teins are highly species-specific proteins and can be pre-
dicted applying the following criteria: (i) hypothetical
protein, (ii) no Sec-signal and (iii) bi-lobed hydrophobicity
profile (Collingro et al., 2011). Twenty-three out of 123
hypothetical proteins (19%) fulfilled these criteria support-
ing the co-purification of ER and SnCV (Supplementary
Table S3). We next grouped the remaining 179 proteins
according to known function or subcellular localisation:
16% of the proteins were ribosomal components, 11%
were localised in the bacterial cytoplasm and 9% were
membrane proteins or belonged to RNA-polymerase,
proton transport, cell surface, helicase or acetyl-CoA car-
boxylase complex (Supplementary Table S3). More inter-
estingly, 20% of the proteins were associated with type III
or Sec-system according to Uniprot and Effectors data-
bases (Supplementary Table S3). We did not detect any
components of the Simkania type IV secretion system.
Comparison of identified proteins with published pan-
genome data (Collingro et al., 2011) showed that 11 out of
the 302 identified proteins are Simkania specific factors
(11/11 hypothetical, 4/11 located on the plasmid pSN),
16/302 proteins showed homologs in Chlamydia and
12/302 proteins are virulence associated, e.g. LPS syn-
thesis proteins or macrophage infectivity potentiator (Sup-
plementary Tables S4 and S5).
The potential subcellular localisation of the identified
human proteins was predicted by database searches
using WEB-based Gene SeT AnaLysis (WEB-Gestalt)
toolkit (Wang et al., 2013) (Fig. 2B). Most of these pro-
teins were predicted by GO annotation as part of macro-
molecular complexes, membrane enclosed lumen and
membrane of the nucleus, cytosol, mitochondria,
cytoskeleton, endomembrane system and ER (Fig. 2B).
We then performed an enrichment analysis using WEB-
Gestalt and GO analysis against the human genome as a
reference set and standard settings with the exception of
top10 significance level and minimum of 10 genes per
category. Enrichment analysis confirmed isolation of
ER-targeted proteins in comparison with the total genome
Simkania, proteomic and lipid trafficking 153
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Fig. 1. Purification of Simkania-containing vacuole (SnCV) and ER membranes.
A. Flowchart showing purification of ER-SnCV-membranes. ER-SnCV-membranes were purified from infected HeLa cells by successive
swelling and lysis steps followed by three sequential centrifugation steps.
B. Phase contrast microscopy of swelling and lysis steps described in A. Cells were equally swollen and visibly broken by mechanical lyses.
C. Immunoblot analysis of purified membrane fractions. Composition of the purified ER-SnCV-membranes is shown by various marker
proteins. Purification led to isolation of mainly ER membrane associated (Calnexin and KDEL) and bacterial proteins (anti-Sn) in the final
fraction (CMF). Soluble ER proteins (Erp72 and PDI) and markers for other cell compartments like mitochondria (Sam50), nuclei (Lamin B1)
and cytoskeleton (ß-Actin) are excluded from the CMF.
D. Transmission electron microscopy of infected PMF (left) and CMF (right) fractions. While the PMF still contained both intact Simkania and
mitochondria, the CMF is devoid of intact bacteria, indicating that purified bacterial proteins might be membrane-associated secreted proteins.
Min = minutes, PNF = pre-nuclear fraction, PMF = pre-mitochondrial fraction, CMF = crude microsomal fraction.
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validating the crude ER-SnCV fraction (CMF) used for the
analysis (Supplementary Fig. S1). Most of the other sig-
nificantly enriched categories were found to be involved
in, e.g., RNA processing and translation (Supplementary
Fig. S1).
The proteome data were further classified by function
like, e.g., protein-, nucleic acid-, ion and metabolic binding
and various enzymatic functions (Fig. 2C). Categorisation
by cellular process indicated that the identified proteins are
involved mainly in metabolic processes but also cellular
component organisation and responses to various stimuli
(Fig. 2D). We next tested for differential expression in
spectral counts between infected and non-infected
samples after adjusting for sample effects using the edgeR
statistical package. A large number of proteins with a
nominal P-value < 0.05 could be identified (Supplementary
Table S2). Comparing the expression of infection-
associated genes across all three samples indicated that
infection in sample 3 did not work (Supplementary Fig. S2).
We focused our further analysis on samples 1 and 2,
which show similar infection-induced regulatory patterns
(Fig. 3A). Six proteins (2’-5’-oligoadenylate synthase
3, Heterogeneous nuclear ribonucleoproteins A2/B1,
Voltage-dependent anion-selective channel protein 1, ATP
synthase subunit beta, Heterogeneous nuclear ribonu-
cleoprotein A0 and ATP synthase subunit alpha) were
differentially regulated after adjusting P-values for multiple
testing (Supplementary Table S2). To allow for explorative
network analysis, we lowered the threshold of adjusted
P-value to < 0.2 now taking into account 51 differentially
expressed genes (Supplementary Tables S2 and S6).
Ingenuity analysis categorised these proteins into 21 sig-
nificant categories, with the top canonical pathways being
involved in mitochondrial dysfunction, oxidative phospho-
rylation, tRNA charging, telomere extension by telomerase
and acetyl-CoA biosynthesis III (Fig. 3B). Network connec-
tivity analysis of these 51 proteins resulted in three major
networks (Fig. 3C–E). We observed a large number of
mitochondrial proteins (F1 ATPase, ATP5A1, ATP5B,
ATP5O, ATP5F1, ATP synthase, VDAC1, TOMM40,
UOCRC2) depleted from the ER/SnCV fraction (Fig. 3C).
Similarly, anterograde transport components (Rab1A,
Rab14, Sec22B) appeared to be depleted in infected cells
(Fig. 3C). Cytoskeletal components and regulators
(ARHGEF2, MSN) especially cytokeratins appear to be
de-regulated (enriched: KRT6A, Cytokeratin, KRT5,
depleted: KRT8, KRT18) while myosins are depleted
(MYH10, Myosin 2) in ER/SnCV from infected cells
(Fig. 3C–E). Taken together, these results provide an over-
view of the proteins regulated in the ER and associated
organelles of Simkania-infected cells.
Some differentially regulated proteins obtained by
LC-MS2 and statistical testing were validated by immuno-
blot (Fig. 3F and G). Interestingly, we observed an enrich-
ment of CCT2 (cytosolic T-complex 1 subunit beta, TCP-
1-B), which forms a complex with CCT1 (cytosolic
T-complex 1 subunit alpha, TCP-1-A) in ER/SnCV fractions
(Fig. 3G). ARHGEF2 (Rho guanine nucleotide exchange
factor 2, GEF H1) was also found to be enriched in purified
membranes from infected cells (Fig. 3G) confirming our
mass spectrometry approach (Fig. 3A, C–E, Supplemen-
tary Tables S1 and S2). Enrichment of ARHGEF2 and
CCT2 at day 3 post infection was not apparent in whole cell
lysates of time course experiments, validating that
enrichment/depletion analysis is not merely due to overall
expressional changes within the cell. In contrast, we
also tested for vesicle-associated membrane protein 2
(VAMP2), voltage-dependent anion channel 1 (VDAC1)
and translocase of outer mitochondrial membrane 40
(TOMM40) and could confirm depletion on day 3 post-
infection both on ER/SnCV as well as whole cell level
(Fig. 3F and G). These results demonstrate that identifica-
tion and quantification of these proteins by mass spectrom-
etry and statistical prediction of protein regulation for day 3
post infection correlated with protein levels in ER/SnCV
membranes detected by immunoblotting.
Endosomal trafficking is required for progeny formation
Chlamydia has developed mechanisms to avoid lysosomal
degradation and acquire lipids via interception of Golgi-
derived sphingomyelin-rich vesicles (Hackstadt et al.,
1995; Scidmore et al., 2003). As acquiring lipids by modu-
lation of cellular trafficking is absolutely essential for Chla-
mydia and proteins associated with anterograde transport
appear to be depleted from the ER/SnCV fraction
(Fig. 3C), we systematically searched our proteomics data
for factors involved in vesicular trafficking. We detected
several additional major regulators of endosomal traffick-
ing (Supplementary Tables S1 and S7). STRING-based
network analysis (von Mering et al., 2003) of these hits
showed that endosomal and exocytic transport as well as
COPII-dependent and -independent ER to Golgi transport
were depleted from the ER/SnCV fraction upon infection
with Simkania (Fig. 4A and corresponding values in Sup-
plementary Table S7). In contrast, proteins of the endoso-
mal recycling pathway were mainly unchanged, whereas
COPI transport was partially enriched (Fig. 4A). Clathrin-
dependent Golgi to ER transport proteins were enriched in
ER/SnCV (Fig. 4A).
This pattern of regulation indicated that Simkania might
require retrograde transport via clathrin- and Golgi-
associated vesicles for nutrient/metabolite acquisition and
growth. To test this assumption, we performed infectivity
assays in cells, which were treated with inhibitors of ret-
rograde trafficking (Retro-1, Retro-2 and VP-184). Retro-1
and Retro-2 have been selected on their activity to inter-
fere with retrograde transport of ricin toxin and Shiga
Simkania, proteomic and lipid trafficking 155
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toxins (Stechmann et al., 2010; Noel et al., 2013). VP-184
is a Retro-1 analogue giving increased protection against
Shiga toxins (J.B. and V.P., unpublished data). Primary
infection measured by inclusion size was slightly reduced
by the inhibition of endosome to Golgi transport using
Retro-1 and -2 (Fig. 4B and C). VP-184 strongly reduced
primary infection and inclusion size at higher concentra-
tions (Fig. 4B and C). Interestingly, all inhibitors strongly
interfered with progeny formation (Fig. 4B, D and E). In
this assay, bacteria are first grown in cells treated with
inhibitors, and the infectious particles from this primary
infection are applied to fresh cells in the absence of inhibi-
tor to measure the bacterial load (GroEL immunoblot) and
inclusion formation (immunofluorescence microscopy).
Thus, all three Retro compounds affect Simkania infection
and SnCV formation during primary infection and progeny
formation.
Next, we performed RNA interference experiments to
specifically address the role of several target proteins. We
concentrated on syntaxin 5 (STX5) (a potential host target
of Retro compounds), coatomer protein complex subunit
2 (COPB2), adaptor-related protein complex 2 subunit
beta1 (AP2B1) and ARHGEF2 (Figs 3C and 4A). Knock-
down efficiency was tested by qRT-PCR and found to be
86% (COPB2), 74% (ARHGEF2), 96% (STX5) and 98%
(AP2B1) (data not shown). Immunoblot analysis of
infected transfected cells showed no changes in primary
infection for ARHGEF2, whereas knockdown of COPB2
(37%), STX5 or AP2B1 (26% or 13%) reduced primary
infection (Fig. 6F). Interestingly, silencing COPB2 and
AP2B1 expression reduced Simkania progeny formation
(27–34%) (Fig. 6F). Taken together, these data confirm
the important role of retrograde trafficking for infection
with Simkania.
Inhibitors of retrograde trafficking cause phenotypic
variations in SnCV formation
Bacterial AB5-toxins, like Cholera- and Shiga toxins, are
transported along the retrograde route from the PM to the
trans-Golgi network (TGN) to reach the ER (Sandvig and
van Deurs, 2002). Retro-1 and -2 specifically block the
early endosome-to-Golgi transport of these toxins without
affecting essential endogenous cargo proteins, protein
biosynthesis or morphology of the ER (Stechmann et al.,
2010; Ming et al., 2013; Noel et al., 2013). As all tested
inhibitors of retrograde transport have had an effect on
primary and progeny infection for Simkania (Fig. 4B–E),
we inspected the subcellular structure of infected cells by
TEM (Fig. 5). A strong inhibition of Simkania replication
was observed at a concentration of 75 μM for Retro-1, -2
and 25 μM for VP-184 (Fig. 4B–E). SnCVs formed nor-
mally in DMSO-treated control cells (Fig. 5A). The SnCV
was smaller in Retro-1-treated cells, and less sub-
vacuoles were visible (Fig. 5B). Retro-2 affected the
SnCV morphology as sub-vacuolar membranes were
highly enlarged and contained excessive membrane
material, probably as a consequence of defective mem-
brane fusion and vacuole formation (Fig. 5C). Parts of the
enlarged sub-vacuoles contained just few bacteria
located at the inclusion boundary, which may indicate
defective Simkania replication. Additionally, sub-vacuoles
were surrounded by multiple membranes at several areas
indicative of a role of Retro-2 inhibited pathways in SnCV
formation and membrane fusion defect. VP-184 seemed
to have an effect on cell growth and development
because infected cells appear smaller than control cells
(Fig. 5D). In line with this, SnCV size and morphology was
also affected in about half of the cells (Fig. 4C). Surpris-
ingly, sub-vacuoles contained small transparent vesicles
of unknown origin and mitochondria were associated with
vesicular structures similar to lipid droplets. Again cellular
effects caused by VP-184 strongly influence SnCV forma-
tion and Simkania replication. The discovery of vesicular
structures inside the SnCV and at the mitochondria indi-
cated a possible shift in lipid metabolism. In summary, all
three Retro compounds have unique effects on the SnCV
morphology suggesting that retrograde transport is
essential for normal development of Simkania.
Inhibitors of retrograde trafficking affect ceramide
transport to the Golgi and the SnCV
Chlamydia acquire lipids for inclusion formation and intra-
cellular replication from secretory pathways (van Ooij
et al., 2000; Carabeo et al., 2003; Heuer et al., 2009;
Derre et al., 2011; Elwell et al., 2011), e.g. by intercep-
tion of SM-containing Golgi-derived exocytic vesicles
Fig. 2. Analysis of the proteome data.
A. Venn diagram indicating the number of proteins identified by LC-MS2. The 1,480 proteins were identified, 1,178 of human and 302 of
Simkania origin (n = 3).
B. Cellular component histogram displays the distribution of the identified human proteins across sub-cellular localisation. Categorisation is
based on GO-annotations allowing multiple localisations. Most proteins are associated with macromolecular complex, membrane enclosed
lumen and membrane. Top sub-cellular localisations were nucleus, cytosol, mitochondrion, endomembrane system and endoplasmic reticulum.
C. Categorisation by molecular function using GO-annotation, multiple terms per protein allowed. Most proteins were associated with
metabolite binding and exerted enzymatic activities.
D. Analysis via biological process histogram using GO-annotations and allowing multiple term per proteins shows that most of the proteins
identified are associated with metabolic functions of the host cell.
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(Hackstadt et al., 1995; Scidmore et al., 1996b; Beatty,
2006; 2008; Robertson et al., 2009). To test if inhibitors of
retrograde transport directly affect cellular transport pro-
cesses to the SnCV, we analysed lipid transport using the
fluorescent ceramide derivative C6-NBD-ceramide in live
cell imaging experiments (Fig. 6A–F, Supplementary
Figs S3 and S4). This fluorescent ceramide provides a
vital stain for the Golgi apparatus (Lipsky and Pagano,
1985b; Pagano et al., 1989; Rosenwald and Pagano,
1993) and is also transported to Chlamydia inclusions
(Hackstadt et al., 1995). NBD-labelled-glucosylceramide
and -sphingomyelin are transported from the PM retro-
grade to the Golgi complex across early and recycling
endosomes (Babia et al., 2001). C6-NBD-ceramide trans-
port to Golgi (mRFP-labelled) and SnCV was monitored
over a time period of 30 min at 1 frame/30 s (Fig. 6A–C) in
the absence or presence of inhibitors of retrograde trans-
port or the previously described Golgi disrupting agent
Brefeldin A (BFA) (Hackstadt et al., 1995; Scidmore et al.,
1996a; Babia et al., 2001) (Fig. 6D–F, Supplementary
Figs S3 and 4). As expected, the C6-NBD-ceramide trans-
fer to mRFP-fluorescent Golgi followed a kinetic similar to
carrier-mediated transport. Signal intensity at the Golgi
was lower during infection but followed a similar kinetic
(Fig. 6A). Fluorescent ceramide that was not taken up by
the Golgi and/or the SnCV was detected in the cell cytosol
(Fig. 6B and C). Analyses of untreated ER-KDEL fluores-
cent cells showed that C6-NBD-ceramide transport ends
at the Golgi apparatus and does not reach the ER (Sup-
plementary Fig. S3A). C6-NBD-ceramide transport was
faster and signal intensity increased at the Golgi in
VP-184-treated non-infected cells compared with control
(Fig. 6D and Supplementary Fig. S3E). In contrast,
Simkania-infected cells showed a strongly reduced
C6-NBD-ceramide transport to the Golgi in the presence
of VP-184 (Fig. 6E, Supplementary Fig. S4B). In accord-
ance with this observation, VP-184 also strongly reduced
the C6-NBD-ceramide signal at the SnCV (Fig. 6F, Sup-
plementary Fig. S4B). C6-NBD-ceramide slightly accumu-
lated in the Golgi in Retro-2-treated cells and infection
strongly increased this effect (Fig. 6D and E, Supplemen-
tary Figs S3D and S4D). Thus, Retro-2 seemed to opti-
mise retrograde lipid-trafficking to the Golgi per se but
especially during infection. This was also observed at the
level of C6-NBD-ceramide SnCV transport, which was
increased in Retro-2-treated cells (Fig. 6F, Supplementary
Fig. S4D). Retro-1 had the similar although milder effect
as Retro-2 (Fig. 6D–F, Supplementary Figs 3C and 4C).
BFA causes disassembly of the Golgi apparatus and
thereby is expected to block C6-NBD-ceramide uptake by
the Golgi. We observed Golgi fragmentation 30 min after
BFA treatment that was followed by reduced fluorescent
lipid uptake and Golgi transport in both non-infected and
infected cells (Fig. 6D and E, Supplementary Figs 3B and
4A). Interestingly, the SnCV showed reduced but not com-
pletely abolished C6-NBD-ceramide levels in the presence
of BFA (Fig. 6F). This result indicates possibly a second-
ary lipid-transport route to the Simkania inclusion. Thus,
the Retro compounds affect C6-NBD-ceramide transport
to the Golgi and to the SnCV, which may explain their
effect on SnCV morphology and bacterial development.
Discussion
Proteomic analysis of isolated pathogen containing vacu-
oles has been successfully applied to many different
bacteria to characterise these unique cellular compart-
ments (Herweg et al., 2015). Proteome analysis of the
Chlamydia-containing vacuole revealed the recruitment
of host cell PM receptors and retromer complexes
(Aeberhard et al., 2015; Mirrashidi et al., 2015; Subbarayal
et al., 2015). Here, we applied a proteomics approach to
investigate the composition of the SnCV and the host ER
with the aim to identify changes in protein composition that
could give us hints on the intracellular accommodation of
Simkania. A crucial step towards this aim was the crude
purification of the SnCV together with ER membranes,
which was probably possible due to a close association of
Fig. 3. Network analysis of proteome data.
A. Heatmap of sample adjusted spectral counts (samples 1 and 2), of edgeR differentially expressed proteins only (raw P-value < 0.05 to 0.2).
B. Pathway enrichment of 51 proteins with adjusted P-values ≤ 0.2 analysed with the Ingenuity software (see Supplementary Table S2). Bars
show the −log (P-value) for the enrichment of proteins of a given group within the list of selected proteins using a right-tailed Fisher’s exact
test. Orange squares show the ratio of proteins detected (within the selected list) among all proteins associated with that group.
C–E. Proteins were clustered into networks of protein–protein interaction based on Ingenuity analysis. Network clustering show e.g. (C)
downregulation of mitochondrial proteins and anterograde transport, de-regulation of cytoskeletal components, (D) upregulation of tRNA
charging and (E) various metabolic functions. The intensity of green and red molecule colours indicates the degree of depletion or enrichment
respectively. Symbols reflect protein class e.g. enzyme and connections depict the way proteins interact (see Supplementary Fig. S5 for
additional information).
F. Immunoblot analyses of crude purified ER-SnCV (CMF) membrane fractions. Calnexin and glycerinaldehyde-3-phosphate dehydrogenase
(GAPDH) were unchanged in ER-SnCV membranes after infection; T-complex 1 related (TCP1/CCT2) and Rho guanine nucleotide exchange
factor 2 (ARHGEF2/GEF H1) were enriched; voltage dependent anion channel 1 (VDAC1) and translocase of outer mitochondria membrane
40 (TOMM40) were depleted.
G. Immunoblot analyses of whole cell lysates from 3 day time-course experiments of infected and control cells. Calnexin and GAPDH are
unchanged in whole cell lysate at 3 days post infection. ARHGEF2/GEF H1 is weakly enriched, TCP1/CCT2 is unchanged, whereas VDAC1,
TOMM40 and VAMP2 (vesicle-associated membrane protein 2) are depleted during infection. Actin was used as loading control.
Simkania, proteomic and lipid trafficking 159
© 2015 John Wiley & Sons Ltd, Molecular Microbiology, 99, 151–171
EsnGroEL
Actin
Retro-1 Retro-2 VP-184 DMSO
 25         75  25         75   25        75 
equi 
75 
1.08       0.82     1.19      0.94      1.11     0.46       1.00     
snGroEL
Actin
Retro-1 Retro-2 VP-184 DMSO
 25        75  25       75  25        75 
equi 
75 





































































siRNASTX5 COPB2 AP2B1 ARHGEF2 con
0.74 0.63 0.87 0.96 1.00
snGroEL
Actin














































0.96 0.66 0.73 1.12 1.00
160 J.-A. Herweg et al. ■
© 2015 John Wiley & Sons Ltd, Molecular Microbiology, 99, 151–171
these membranes and ER contact sites. Although direct
information on trafficking pathways cannot be deduced
from these proteomics data, the composition of the com-
partment can be estimated. We could use these semi-
quantitative data and protein interaction predictions to
identify complex networks of interacting proteins including
transport processes with infection-dependent enrichment
or depletion.
Intracellular pathogens frequently escape from the
phagolysosomal route to prevent lysosomal degradation.
Although initially believed to be exceptions, pathogen-
containing compartments with ER or Golgi features
(Desjardins, 2003) have been meanwhile demonstrated
for the important pathogens Brucella (Anderson and
Cheville, 1986; Pizarro-Cerda et al., 1998), Legionella
(Horwitz, 1983; Swanson and Isberg, 1995; Tilney et al.,
2001) and Chlamydia that replicate in vacuoles receiving
lipids from the TGN (Heinzen et al., 1996). Legionella and
Brucella interfere with the biogenesis of the early
phagolysosome modulating their vacuolar composition to
mature into in ER-derived compartments (Desjardins,
2003). Like many other bacteria, all Chlamydiae develop
and multiply within a unique vacuole, which is not acidified
(Friis, 1972; Lawn et al., 1973; Wyrick and Brownridge,
1978; Heinzen et al., 1996; Al-Younes et al., 1999; Rockey
et al., 2002). However, also Chlamydia-like organisms,
such as Parachlamydia acanthamoebae, Simkania
negevensis and Waddlia chondrophila grow in similar
vacuoles in amoebae and cells of higher animals (Everett,
2000). Similar to Legionella pneumophila and Brucella
abortus, C. trachomatis uses host cell Golgi- and/or
ER-derived vesicles to generate specialised membrane-
bound compartments for the replication. We previously
showed that Simkania establishes novel ER interaction
sites at which the SnCV is extended along the ER within 3
days post infection (Mehlitz et al., 2014). It is likely that
Simkania uses host cell Golgi- and/or ER-derived lipids
and vesicles to generate the SnCV compartment.
Positive-strand RNA viruses are known to remodel
intracellular membranes to create mini-organelles where
RNA amplification and virion assembly take place (Miller
and Krijnse-Locker, 2008). Flaviviruses like dengue virus
and West Nile virus have been shown to replicate within
membrane invaginations originating from the ER (Welsch
et al., 2009; Gillespie et al., 2010). Hepatitis C virus most
likely uses specialised vesicles for RNA replication that
are derived primarily from the rough ER, early and late
endosomes, COP vesicles, mitochondria and lipid drop-
lets (Romero-Brey et al., 2012). We identified analogue
cellular components in the proteome data indicating that
vacuole formation processes are similar for Simkania.
Interestingly, most proteins identified here are part of
clathrin and COPI vesicle transport pathways (retrograde)
that were enriched during infection whereas most exocytic
and endosomal as well as COPII or other ER to Golgi
transport proteins (anterograde) were depleted. This was
the first hint that retrograde transport plays an important
role in SnCV formation. Additionally, silencing COPB2
(COPI) and AP2B1 (clathrin) expression reduced the pro-
duction of Simkania infectious progeny.
We demonstrated here a strong effect of Retro com-
pounds on SnCV maturation and Simkania development.
These inhibitors have initially been identified as com-
pounds that prevented the cytotoxic effect of toxins that
are transported via the retrograde route (Stechmann
et al., 2010; Ming et al., 2013; Noel et al., 2013). Although
the exact molecular targets of these compounds have not
been identified yet, it is likely that the retrograde transport
Fig. 4. Regulation of endosomal and retrograde trafficking during Simkania infection. Filtering of the proteomic data showed that 57 human
proteins are involved in cellular transport processes e.g. endosomal and exocytic trafficking (see Supplementary Table S7).
A. STRING-based protein network analysis highlights sub-networks of similar regulation representative of different cellular transport routes.
Enriched (green) (Kahane et al.) and depleted (red) (Bravo et al.) proteins (regulation > ± 0.20 logFC) are clustered in several sub-networks
involved in COPII-/ER to Golgi, exocytic, recycling endosomal, endosomal, clathrin and COPI (Golgi to ER) transport. Unchanged (yellow)
proteins (regulation < −0.20 logFC) mostly form loosely network nodes. Several Golgi to ER and clathrin-derived vesicle proteins were
enriched or unchanged, whereas ER to Golgi, endosomal and exocytic proteins were depleted.
B. HeLa cells were infected with Simkania at moi 0.5 for 3 days in the presence of inhibitors of retrograde trafficking (Retro-1, Retro-2 and
VP-184). Immunoblots show bacterial growth via Simkania GroEL (snGroEL) levels in primary as well as progeny infection. Primary infection
decreased in the presence of Retro-1 and -2 inhibitors of retrograde trafficking. The negative effect on bacterial replication mediated through
Retro-1 and -2 became more pronounced in progeny formation. VP-184 showed a more pronounced effect during primary infection and
strongly prevented formation of infective progeny. ß-Actin was used as protein loading control.
C–D. Bar diagram showing the analysis of infectivity assays from cells treated as described in B. P ≤ 0.05 = *, P ≤ 0.01 = **, P ≤ 0.001 = ***,
n = 4. (C) Relative inclusion size of Simkania-containing vacuoles (SnCVs) was detected by using ImageJ. The average size of SnCVs
decreased upon Retro compound treatment. (D) Analysis of inclusion number from progeny infection. As observed in B. reduction in inclusion
number became more pronounced in progeny infection.
E. Immunofluorescence images of HeLa progeny cells after 3 days incubation. Nuclei were stained for DAPI (green) (Kahane et al.) and
SnCVs were stained for GroEL (red) (Bravo et al.). Inhibitor-treatment reduced Simkania progeny formation. (B–E) Images are representative
of n = 3 independent experiments.
F. HeLa cells were RNAi treated (STX5, ARHGEF2, COPB2, AP2B1 or AllStars negative control) and infected with Simkania at moi 0.5 for 3
days. Immunoblots show bacterial growth via snGroEL levels in primary as well as progeny infection. Primary infection was decreased in
COPB2 and slightly decreased in STX5 or AP2B1 knockdown. Interestingly, COPB2 as well as AP2B1 decreased progeny formation. ß-Actin
was used as loading control, n = 3.
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Fig. 5. Effects of Retro compounds on SnCV formation during Simkania infection. Transmission electron microscopy of HeLa229 cells 3 days
post infection. Cells were treated with 75 μM DMSO, Retro-1, -2 and 25 μM VP-184 during infection. The SnCV (red) (Bravo et al.), associated
to mitochondria (green) (Kahane et al.), spreads the cytoplasm near the nucleus (blue). A. The DMSO control shows a normal SnCV highly
filled with bacteria that are covered with mitochondria. B. Retro-1 seems to affect SnCV size indicated by fewer small sub-vacuoles. C.
Retro-2 seems to affect SnCV morphology and bacteria replication. Sub-vacuoles that are highly enlarged contain just few bacteria that are
located at the SnCV boundary (blue arrows) and/or contain excessive membrane material (orange arrows). Some sub-vacuoles are
surrounded by multiple membranes (yellow arrows). In total, the SnCV appears to be bigger in size. D. VP-184 affects cell development and
SnCV size. Sub-vacuoles contain freestanding transparent vesicles of unknown origin (yellow arrows). Some mitochondria are associated with
transparent droplets of unknown origin (white arrows).
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Fig. 6. Effects of Retro compounds on Golgi-dependent sphingomyelin transport to the SnCV. Time-courses of life cell imaging from
intracellular C6-NBD-ceramide transport in Simkania-infected or control HeLa Golgi-mRFP cells are shown. (A, D–E) Calculation of
fluorescence intensity of C6-NBD-ceramide trafficking to the Golgi apparatus and (F) to the SnCV within 30 min (2 images/frame). Curves are
representative of n = 3 biological experiments and m ≥ 20 cells/experiment. (B–C) Time-course images of C6-NBD-ceramide transport in
untreated Simkania- and non-infected HeLa cells. Red = Golgi; green = C6-NBD-ceramide. Brefeldin A = BFA. Images are representative of
n = 3 independent experiments.
A. C6-NBD-ceramide transport to the Golgi rises exponentially. Simkania-infected cells (orange) absorb more slowly and less of the fluorescent
ceramide compared to non-infected cells (blue). The maximum gain is reached at around 28–30 min.
B. Time-course images of C6-NBD-ceramide transport in non-infected cells. Images of 2.5 min time lags starting at 0 min are illustrated.
C. Time-course images of C6-NBD-ceramide transport in Simkania-infected cells. Images of 2.5 min time lags starting at 0 min are illustrated.
D. C6-NBD-ceramide to Golgi transport in non-infected and Retro compound-, BFA- or untreated cells was analysed. Inhibitors were added
30 min prior to imaging (for more details, see Experimental procedures section). VP-184-treated cells (violet) showed a high increase that
slightly dropped down at 12–13 min. Retro-2-treated cells (grey) showed a slight increase compared with the control (blue). Retro-1-treated
cells (red) (Bravo et al.) showed a slight decrease. In BFA-treated cells (yellow) the transport was really weak.
E. C6-NBD-ceramide to Golgi transport in Simkania-infected and Retro compound-, BFA- or untreated cells was analysed. In Retro-1- and
-2-treated cells (red, grey) the fluorescent lipid transport to the Golgi was highly increased. In VP-184 and BFA-treated cells (violet, yellow),
the transport was weaker but still detectable.
F. C6-NBD-ceramide to SnCV transport in Simkania-infected and Retro compound-, BFA- or untreated cells was analysed. In Retro-1- and
-2-treated cells (red, grey) the fluorescent lipid transport to the SnCV was highly increased. VP-184-treated cells (violet) showed a slight
increase that dropped down nigh the Sn-control (orange). In BFA-treated cells (yellow) the transport was weaker but still detectable.
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is already blocked early at the level of endosomal to TGN
trafficking. We showed that Retro compounds influence
intracellular SnCV formation and Simkania development.
Electron microscopy studies indicated a strong effect on
the SnCV morphology that appears to be unique for every
compound. This diversity may reflect the inhibition of dif-
ferent targets by Retro compounds and – in line with this
assumption – also different pathways of vesicular trans-
port that all are required for SnCV formation.
In the process of inclusion formation, Chlamydiae
actively interrupt the classical endocytic pathway very
early (Scidmore et al., 1996a) and enter the cells’ exocytic
pathway that remains poorly defined (Hackstadt et al.,
1995; 1997; Rzomp et al., 2003). In this study, we con-
centrated on retrograde trafficking as proteins controlling
clathrin vesicle and COPI-Golgi to ER transport appeared
enriched during Simkania infection. Retrograde transport
involves proteins and lipids that initially are transported
back from the PM and endosomes to the Golgi apparatus.
Recycling endosomes serve here as a sorting organelle
for retrograde transport (Bonifacino and Rojas, 2006).
Subsequently proteins and lipids are transported within
the TGN to the ER (Sandvig and van Deurs, 2005), which
is mediated by COPI vesicles (Orci et al., 1997). Many
viruses use similar routes to the ER for their assembly
(Brandenburg and Zhuang, 2007). Recently, it was
reported that Retro-2 can inhibit retrograde transport of
polyoma-, papilloma- and adeno-associated viruses sug-
gesting an overlap in the host factors used by bacterial
toxins and viruses (Nelson et al., 2013; Carney et al.,
2014; Nonnenmacher et al., 2015). Our data using Retro
compounds and RNA interference during Simkania infec-
tion support that the SnCV is dependent on retrograde
transport. It is likely that retrograde transport is required
for nutrient acquisition during Simkania infection. There-
fore, compounds like Retro-1 or -2 might be useful to
hinder infection by Simkania and maybe Chlamydia as
well, as they also require early endosome-to-Golgi and
Golgi to ER transport for infection.
Metabolite delivery to the SnCV appears to be one of
the processes that are influenced by Retro-1 and -2.
Treatment with Retro-1 and -2 increased the amount of
C6-NBD-ceramide in the Golgi and the SnCV, probably
due to the interference of both inhibitors with the transport
of C6-NBD-ceramide from the TGN, which could result in
retention in the Golgi and increased uptake by the SnCV.
VP-184 had the most dramatic effect by causing strong
retention in the Golgi only in non-infected cells and
blocked C6-NBD-ceramide transport to the Golgi after
infection. In infected cells, the effect of VP-184 was similar
to BFA, a Golgi-disrupting compound, and lipid accumu-
lation in the Golgi was not detected at all, pointing to an
infection-dependent block of lipid transport at the Golgi
under these conditions. C6-NBD-ceramide transport to the
SnCV seemed to be affected by this block at later time
points. The finding that BFA prevented accumulation of
C6-NBD-ceramide in both the Golgi and the SnCV adverts
to a role of the Golgi in lipid transport to the SnCV.
The chlamydial inclusion is not permeable to molecules
as small as 520 Daltons (Heinzen and Hackstadt, 1997)
and therefore, all larger metabolites and proteins have to
cross the membrane barrier either by direct transport or by
delivery via vesicle involving both human and bacteria
proteins in the inclusion membrane. We used C6-NBD-
ceramide, a vital stain for the Golgi apparatus that has
been used to study sphingolipid trafficking in viable cells
(Lipsky and Pagano, 1985a,b; Pagano et al., 1989;
Rosenwald and Pagano, 1993; Zhong et al., 2001). Within
the cis or medial Golgi apparatus, C6-NBD-ceramide is
processed to sphingomyelin (SM) or glucosylceramide,
like endogenous ceramide (Lipsky and Pagano, 1985a),
and delivered to the PM by a vesicle-mediated pathway.
By interruption of exocytic lipid transport, C. trachomatis
(Scidmore et al., 1996b), C. psittaci (Rockey et al., 1996)
and C. pneumoniae (Wolf and Hackstadt, 2001) intercept
the fluorescent SM that subsequently is incorporated into
the cell wall of the intracellular bacteria. This modification
of intracellular lipid trafficking by induced fusion of the
inclusion with a subset of exocytic vesicles leads to the
acquisition of a significant amount of the exported SM
(Fields and Hackstadt, 2002). Simkania like other Chla-
mydia species (Fritsche et al., 2000) lack genes for SM
biosynthesis and therefore likely intercept SM by exploit-
ing the host cell ceramide transport. Prolonged treatment
with BFA causes disassembly of the Golgi apparatus and
induces redistribution of Golgi, secretory and membrane
proteins into the ER. BFA has been shown to abrogate SM
transport to the chlamydial inclusion (Scidmore et al.,
1996b). We observed that BFA generally blocks C6-NBD-
ceramide uptake, indicating an early inhibition of cera-
mide transport already at the PM. Despite advanced Golgi
fragmentation in BFA-treated cells, small amounts of
ceramide were incorporated into the SnCV, suggesting
that Simkania gains the main part of ceramide directly
from the Golgi but uses also other pathways for lipid
acquisition. The enhanced accumulation of ceramide in
the SnCV could be directly stimulated by the blocked
transport to or out of the Golgi (treatment with Retro-1,
Retro-2, perhaps also VP-184) resulting in increased
transfer of ceramide to other transport pathways, e.g.
clathrin-derived vesicles. This is supported by similar find-
ings on retrograde toxin transport in Vero cells (Schapiro
et al., 1998) as well as enrichment of clathrin-associated
proteins like AP2A1 and AP2B1 found in our LC-MS2
analysis. BFA treatment has no effect on Chlamydia rep-
lication (Scidmore et al., 1996b), suggesting that C. tra-
chomatis acquires SM by additional routes that involve
BFA-insensitive and/or non-vesicular trafficking pathways
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(Derre et al., 2011; Elwell et al., 2011; Dumoux et al.,
2012). These may involve bacterial effector proteins as in
case of Salmonella, where the SPI-2 effector SseL binds
to a lipid-binding protein and may direct host lipid-
transport to the Salmonella-containing vacuole (Auweter
et al., 2012).
We show here that early events in retrograde transport
seem to be essential for SnCV formation, Simkania devel-
opment and ceramide acquisition. Because we do not
know the targets of the Retro compounds, the affected
trafficking pathways remain to be defined. We cannot
exclude COPI-dependent and independent pathways of
retrograde transport, the ERGIC as first anterograde and
retrograde sorting station or the influence of depleted
anterograde transport proteins during infection. We
hypothesise that the enrichment of clathrin or Golgi to ER
transported proteins in addition to the depletion of many
anterograde transported proteins indicates a direct
bypass of important nutrient trafficking pathways to the
SnCV during infection. Further studies are necessary to
understand the influence of retrograde and anterograde
transport on Simkania development.
Experimental procedures
Cell lines and bacteria
HeLa229 (ATCC CCL-2.1) were grown in RPMI1640 medium
(Glutamax, 10% FBS, w/o HEPES) (Invitrogen). Stable
HeLa229 cell lines were established to constantly label the
Golgi apparatus (B4GalT1 in a pCMV6-AC-mRFP cloning
vector, OriGene) and the ER (KDEL in a pDsRed2-ER expres-
sion vector). Selection for B4GalT1-mRFP or KDEL-DsRed2
was done with G418 (400 μg/ml). S. negevensis strain Z
(ATCC VR-1471) was prepared as described previously
(Mehlitz et al., 2014). Briefly, HeLa229 cells were grown to
50–70% confluence and were inoculated with S. negevensis in
RPMI1640 with 5% FBS, for 6 h at 35°C in a humidified
incubator at 5% CO2. Medium was replaced by infection
medium (RPMI1640, Glutamax, 5% FBS, w/o HEPES), and
growth was allowed for 3 days. Cells were mechanically
detached, and bacteria were released using ∼ 2–5 mm glass
beads (Carl Roth). Low speed supernatant (600 × g, 4°C
and 5 min) was subjected to high-speed centrifugation
(20 000 × g, 4°C and 30 min) to pellet bacteria. Bacteria were
washed twice with 5 ml SPG (250 mM sucrose, 50 mM
sodium phosphate, 5 mM glutamate, pH 7.4), aliquoted and
stored at −80°C in SPG.
ER-SnCV purification
HeLa229 cells were seeded in 6-well cluster plates (12 plates/
experiment) and grown to 70% confluence before infection
with Simkania at multiplicity of infection (moi) 1.0 (see also
Fig. 1A for experimental scheme). Plates were centrifuged for
1 h at 4°C, 910 × g and inoculated for 5 h at 35°C in a humidi-
fied incubator at 5% CO2. Medium was replaced by infection
medium and growth was allowed for 3 days. Growth medium
was removed, and cells were released with a rubber police-
man into ice-cold PBS followed by one wash step ice cold PBS
(5 min, 4°C, 600 × g). PBS was replaced by 600 μl 0.5 ×
hypotonic buffer (10 mM HEPES, 0.5 mM EGTA, 12.5 mM
KCl, 0.125 M sucrose, protease and phosphatase inhibitors,
pH 7.6), and cells were incubated for 20 min at 4°C in a rotary
shaker. Cells were pelleted (5 min, 4°C, 600 × g) and resus-
pended in 0.5 × isotonic buffer (5 mM HEPES, 0.5 mM EGTA,
12.5 mM KCl, protease and phosphatase inhibitors, pH 7.6)
and sonicated at 4°C for 10 min in a sonication bath. Pre-
lysate was homogenised with a Dounce Homogenizer (glass
cylinder and pestle), 10 strokes at 200 r.p.m. Crude microso-
mal fraction containing ER and SnCV were prepared by
sequential centrifugation: (i) pre-nuclear fraction (PNF) –
1,000 × g at 4°C for 10 min; (ii) pre-mitochondrial fraction
(PMF) – 12 000 × g at 4°C for 15 min and (iii) crude microso-
mal fraction (CMF) – 100 000 × g at 4°C for 1 h in an Optima
MAX-XP ultra-centrifuge using a MLA-80 fixed angle rotor
(Beckmann Coulter).
Reagents and antibodies
Chemicals were obtained from Sigma-Aldrich (Germany)
unless otherwise stated. Primary antibodies used: Calnexin
(Cell Signaling, C5C9), PDI (Cell Signaling, C81H6), ERp72
(Cell Signaling, D70D12), KDEL (Enzo, 10C3), Lamin B1
(Santa Cruz, 6216), Sam50 (kindly provided by Vera Kozjak-
Pavlovic), β-Actin (Sigma-Aldrich, A5441), CCT2 (Cell Sign-
aling, 3561), GEF H1 (55B6) (Cell Signaling, 4076), VDAC1
(Calbiochem, 529532), TOMM40 (Santa Cruz, sc-11414) and
VAMP2 (D601A) (Cell Signaling, 13508). Antibodies against
GroEL (anti-Sn-GroEL) or whole bacteria (anti-Simkania)
were prepared as previously described (Mehlitz et al., 2014).
Carbocyanine-labelled secondary antibodies were pur-
chased from Dianova. Nuclear staining was done with 4’,
6-diamidino-2-phenylindole (DAPI). Fluorescent sphingolipid
NBD-C6-ceramide (6 – ((N – [7 – nitrobenz – 2 – oxa – 1, 3 –
diazol – 4 – yl) amino) hexanoyl] sphingosine) complexed to
BSA was obtained from Molecular Probes (Invitrogen,
N-1154). G418 was obtained from InvivoGen. Protease and
phosphatase inhibitors were obtained from Roche.
Immunoblotting and immunofluorescence staining
Western blotting was performed according to standard pro-
cedures (Mehlitz et al., 2010), and signals were detected with
a Chemo Cam Imager (Intas). Quantification was performed
using FIJI (ImageJ) and Excel (Microsoft). For immunofluo-
rescence, cells were seeded in 12-well cluster plates with or
without coverslips and were infected in a humidified incubator
at 35°C and 5% CO2 with mois indicated in the respective
experiments. Cells were fixed at indicated time points with
4% PFA-sucrose for 25 min, washed once with PBS and
stained while gently shaking. Subsequently cells were per-
meabilised with 0.2% Triton X-100 in PBS for 45 min and
washed 3 × with PBS for 15 min at RT. Cells were blocked
with 2% goat serum in PBS for 60 min and were stained with
primary antibodies diluted in 2% goat serum in PBS for 24 h
at 4°C. After 3 × washing with PBS for 15 min, samples were
incubated with secondary antibodies for 1 h in blocking solu-
tion at RT in the dark. Cells were washed 3 × with PBS and
counterstained with DAPI (1 μg/ml) in PBS for 15 min. Cov-
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erslips were mounted with Mowiol 4–88 (Carl Roth) after
short wash with H2O. The 12-well cluster plates without cov-
erslips were washed 3 × with PBS for 15 min and visualised
at RT. Samples were subsequently viewed on either a Leica
DMIR or TCS SP5 microscope (Leica Microsystems GmbH,
Wetzlar, Germany), respectively. Data were processed using
FIJI (ImageJ) (http://fiji.sc/) (Laboratory for Optical and Com-
putational Instrumentation (LOCI), University of Wisconsin-
Madison, USA).
Electron microscopy
Samples were fixed with 2.5% glutaraldehyde (50 mM
sodium cacodylate pH 7.2; 50 mM KCl; 2.5 mM MgCl2) at 4°C
for 1 h and buffered with 50 mM sodium cacodylate (pH 7.2)
at 4°C. Then samples were incubated with OsO4 for 2 h at
4°C. Cells were dehydrated, embedded in Epon812 and
ultrathin sectioned at 50 nm. Sections were stained with 2%
uranyl acetate in ethanol, followed by staining with lead
citrate and analysed on a Zeiss EM10 (Zeiss, Germany).
LC-MS/MS
For LC-MS2 measurements, three biological replicates of
ER-SnCV purified samples were generated and analysed.
Proteins were separated by 1D-SDS-PAGE, the gel lanes
were excised in 10 equidistant pieces and subjected to
trypsin digestion as described before (Otto et al., 2010). For
LC-MS/MS analyses, in-house self-packed columns were
prepared and used with an EASY-nLC II system (Thermo). In
brief fused silica emitter tips with an inner diameter of 100 μm
and an outer diameter of 360 μm were prepared by using a
P-2000 laser puller (Sutter Instruments, Novato, CA). The
resulting emitter tip was then packed with Phenomenex Aeris
C18 reversed phase material (3.6 μm particles) in custom
build pressure bomb to obtain a 20 cm nano-LC column.
The peptides were loaded onto the column with 10 μl buffer
A (0.1% acetic acid) at a constant flow rate of 500 nl/min
without trapping. Subsequently, peptides were eluted using a
non-linear 180 min gradient from 1% to 99% buffer B (0.1%
acetic acid in acetonitrile) with a constant flow rate of 300 nl/
min and injected online into the mass spectrometer. Voltages
between the emitter capillary and the orifice were set to
2.5 kV by using liquid junction. Afterward, the column was
washed with 99% buffer B for 5 min and equilibrated with
99% buffer A for 18 min. The gradient is described in Table 1.
MS and MS/MS data were acquired with a LTQ Orbitrap
Classic (Thermo). After a survey scan at a resolution of
R = 30 000 within a scan range (m/z) of 300–2000 in the
Orbitrap with activated lockmass correction, the five most abu-
ndant precursor ions were selected for fragmentation. Singly
charged ions as well as ions without detected charge states
were not selected for MS/MS analysis. CID fragmentation
was performed for 30 ms with normalised collision energy
of 35, and the fragment ions were recorded in the linear ion
trap.
After mass spectrometric measurement, MS data were
subjected to database searching via Sorcerer using Sequest
(version 27, revision 11; SageN, Milptas, CA, USA) without
charge state deconvolution and deisotoping performed. Data-
base searching was performed with a database of combined
entries of NCBI Simkania negevensis NC 015713 and NC
015710 and UniProtKB Homo sapiens (version 2/12). The
combined database was used as target/decoy databases
with a list of common contaminants added (45580 entries).
Sequest was used assuming trypsinisation with a fragment
ion mass tolerance of 1.00 Da and a search tolerance of
10 ppm for the overview scans. Oxidation of methionine was
specified in Sequest as a variable modification. Scaffold
(version 3.5.1, Proteome Software, Portland, OR, USA) was
used to filter and validate MS/MS-based peptide and protein
identifications. Peptide identifications were accepted when
spectra exceeded Xcorr values of 2.2, 3.3 and 3.8 for doubly,
triply and quadruply charged peptides with deltaCN values of
more than 0.1. Protein identifications are based on at least 2
unique peptides. Proteins that contained similar peptides and
could not be differentiated based on MS/MS analysis alone
were grouped to meet the principle of parsimony.
Analysis of proteomics data
Proteomics data were analysed via Web-based Gene SeT
AnaLysis Toolkit (WEBGestalt) (Wang et al., 2013). Enrich-
ment analysis was performed using GO Analysis against the
Homo sapiens genome. WEBGestalt settings were hypergeo-
metric statistical method and multiple test adjustment accord-
ing to Benjamini and Hochberg (1995). Significance levels
allowed only the top 10 categories at a minimum protein
number of 10 per category. Proteomic count data was filtered
using Scaffold as described above (LC-MS/MS). Differential
expression was analysed using the edgeR method (Robinson
et al., 2010) as implemented in the statistical package msm-
sTest (Gregori et al., 2013) in the software R. Given the
uncertainty of normalisation factor estimation due to the rela-
tively small in number and possibly selected set of proteins
detected we did not normalise counts across samples by
default. Estimated normalisation factors for paired samples
showed that those were rather small (< 0.1-fold difference for
all pairs). We used a model incorporating each experiment as
blocking factor to perform paired tests. As a sensitivity analy-
sis, we repeated the analysis using edgeR’s global normalisa-
tion method, which resulted in the same list of differentially
expressed genes (adjusted P < 0.2) except for proteins
HNRPC, K1C18, K2C8, SFXN1, AHNK, PABP1, ATPO and
SEPT2. Heatmaps were generated after a variance stabilising
transformation as provided by package DESeq (Love et al.,
2014), adjusting for experiment effects using the same model
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as above. Trafficking proteins were further analysed via
‘Search Tool for the Retrieval of INteracting Genes/proteins’
(STRING) (von Mering et al., 2003) allowing standard setting
for predictive methods (Neighbourhood, Gene Fusion,
Co-occurrence, Co-expression, Experiments, Databases and
Textmining) at medium confidence (0.4).
Infectivity assays
The 40 000 cells were seeded in 12-well cluster plates,
inhibitor-treated and infected as indicated in the respective
experiment. Cells were processed for immunoblotting,
immunofluorescence staining or infectivity assay. For infec-
tivity assays cells were either fixed and stained at indicated
time points (inclusion formation/primary infection) or bacte-
ria were released via one freeze thaw cycle (−70°C/37°C)
followed by mechanical release through pipetting and trans-
fer to fresh HeLa229 cells (1:25–1:50, progeny/infectivity).
Cells were centrifuged for 1 h at 35°C and medium
exchanged to infection medium. Progeny was fixed at day 3
post infection and processed for staining or harvested for
immunoblotting. Infectivity assays were imaged on an auto-
mated fluorescence microscope Leica DMIR. Numbers and
average sizes of the SnCV as well as host cell numbers
were determined via GroEL and DAPI staining, and images
were analysed and quantified using FIJI (ImageJ) and Excel
(Microsoft).
siRNA transfections
SiRNA against STX5 (GS6811), COPB2 (GS9276), AP2B1
(GS163), All-Stars negative control (SI03650325) were pur-
chased from Qiagen. ARHGEF2 siRNA was obtained from
Dharmacon (M-009883-01-0005). Transfection was done
using HiPerFect transfection reagent (301705) as described
in the manufacturer’s instructions (Qiagen).
RNA isolation and qRT-PCR
RNA was isolated using TRI reagent solution (Ambion,
AM9738) according to manufacturer’s instructions. Instead of
BCP, we used 200 μl chloroform. Total RNA concentration
was determined by using a NanoDrop fluorospectrometer
(Thermo Scientific). Synthesis of first strand cDNA was per-
formed on 1–2 μg total RNA by using RevertAid RT Reverse
Transcription Kit (Thermo Fisher, K1691). QRT-PCR was per-
formed on 20 μl reaction volumes in triplicates using SYBR
green master mix (Quanta, 733–1386) according to the
manufacturer’s instructions. qRT-PCRs were performed on a
StepOnePlus instrument (Applied Biosystems, 96 wells), and
data were analysed using the ΔΔCT – method and StepOne
software v2.3 (Applied Biosystems). Primers used were
AP2B1: 5′-CCAGAGCATTGATGTCTCCC-3′ (F), 5′-GGGAT
GAGGCAGCTGAAGTA-3′ (R); ARHGEF2: 5′-CTCGAAAG
AAAGTTGCTCCG-3′ (F), 5′-ACAGGCATAGCACATGGT
CA-3′ (R); COPB2: 5′-GTAGCCGGTAACAAACGAGG-3′ (F),
5′-CCAACATCCATGGCTCTGTA-3′ (R); STX5: 5′-TGAGT
TGGGCTCCATCTTTC-3′ (F), 5′-TTGAGGATCTCTGAATGG
GC-3′ (R).
C6-NBD-ceramide labelling and life cell imaging
The 100,000–150,000 cells were seeded in ibidi μ-dishes,
35 mm, high (Ibidi). Cells were infected with S. negevensis for
6 h at 35°C in a humidified incubator at 5% CO2. Medium was
replaced by infection medium, and growth was allowed for 3
days. Medium was exchanged 30 min prior to imaging with
PBS and 1 ml of pre-warmed RPMI1640 medium (Glutamax,
w/o FCS, 25 mM HEPES, w/o phenol red) containing inhibitors
at following concentrations: 0.2 μg/ml BFA, 25 μM VP-183,
75 μM Retro-1 or 75 μM Retro-2. For imaging, cells were
transferred to a pre-warmed microscopy chamber mounted to
a Leica TCS SP5 microscope. μ-dishes were imaged without
lid and after focusing cells were initially imaged 2 min for
system stability (two images/minute). Experiments were
started adding 10 μl of 50 μM C6-NBD-ceramide in PBS to the
pre-focused cells, and imaging was allowed to proceed for at
least 28 min at two images per minute. Ceramide uptake was
quantified by setting a region of interest around the Golgi or
within the SnCV and measuring the C6-NBD intensity using
ImageJ. C6-NBD uptake in the respective area was normalised
to C6-NBD intensity at time point t = 0. Intensity ratios were
calculated with Excel (Microsoft).
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